1001 - 1025 of 8587 Results
Title
Year
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
-
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
-
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
-
RESTRICTED
-
RESTRICTEDTitle: Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental SciencesJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.168132856.66485758Citation Count: 1
-
RESTRICTED
- Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small Dataset2020RESTRICTEDTitle: Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small DatasetJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.21203/rs.3.rs-19405Citation Count: 3
-
RESTRICTEDTitle: Neurochemical biomarkers in the differential diagnosis of movement disordersJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 10Start Page: 1411End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22510Citation Count: 43
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
- Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation2020RESTRICTEDTitle: Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammationJournal Name: Seminars in ImmunopathologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 6Start Page: 681End Page: 696Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00281-020-00819-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00281-020-00819-8.pdfCitation Count: 10
-
RESTRICTEDTitle: Inflammation in Experimental Models of α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 37End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28264Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115204Citation Count: 24
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
- Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophrenia2020RESTRICTEDTitle: Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophreniaJournal Name: Brain InformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40708-020-00112-2Best OA location URL: https://braininformatics.springeropen.com/track/pdf/10.1186/s40708-020-00112-2Citation Count: 182
- Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 Mutation2021RESTRICTEDTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296;Citation Count: 1
-
RESTRICTEDTitle: Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Journal Name: Nature Reviews NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 2Start Page: 115End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41583-021-00542-9Citation Count: 90
- Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications2015RESTRICTEDTitle: Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational ModificationsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1210End Page: 1227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031210Best OA location URL: https://www.mdpi.com/2218-273X/5/3/1210/pdf?version=1435227112Citation Count: 12
-
RESTRICTEDTitle: The Effects of Physical Activity in Parkinson’s Disease: A ReviewJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 6Issue #: 4Start Page: 685End Page: 698Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160790Best OA location URL: https://europepmc.org/articles/pmc5088404?pdf=renderCitation Count: 138
- High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease2021RESTRICTEDTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8;Citation Count: 68
-
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development2019RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name:Publisher:Vol:Issue #:Start Page: 216847901881751End Page: 216847901881751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/2168479018817517;Citation Count: 21
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name:Publisher:Vol:Issue #:Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866;Citation Count: 9
-
RESTRICTEDTitle: Preventing Parkinson’s Disease: An Environmental AgendaJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 1Start Page: 45End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212922Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212922?id=journal-of-parkinsons-disease%2Fjpd212922Citation Count: 58